Akanda Corp - Asset Resilience Ratio
Akanda Corp (AKAN) has an Asset Resilience Ratio of -0.19% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how Akanda Corp's Asset Resilience Ratio has changed over time. Check AKAN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Akanda Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Akanda Corp.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-18.72K | -0.19% |
| Total Liquid Assets | $-18.72K | -0.19% |
Asset Resilience Insights
- Limited Liquidity: Akanda Corp maintains only -0.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Akanda Corp Industry Peers by Asset Resilience Ratio
Compare Akanda Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Livzon Pharmaceutical Group Inc
SHE:000513 |
Drug Manufacturers - Specialty & Generic | 2.93% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Canopy Growth Corp
TO:WEED |
Drug Manufacturers - Specialty & Generic | 15.73% |
|
LAVIPHARM S.A. NA EO 1
F:BXA0 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Akanda Corp (2021–2023)
The table below shows the annual Asset Resilience Ratio data for Akanda Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $8.84 Million | -- |
| 2022-12-31 | 0.68% | $263.69K | $39.00 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $8.05 Million | -- |
About Akanda Corp
As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.